- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 84-98 of
215 results
1007 Exhibit: US Application No 12621,502, Response to Office Action dated Dec 1...
Document
IPR2018-00685, No. 1007-7 Exhibit - US Application No 12621,502, Response to Office Action dated Dec 18, 2013 (P.T.A.B. Feb. 23, 2018)
|
|
Cite Document
1014 Exhibit: Wiernik, PH et al, Lenalidomide Monotherapy in Relapsed or Refracto...
Document
IPR2018-00685, No. 1014-14 Exhibit - Wiernik, PH et al, Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non Hodgkin¿¿¿s Lymphoma (P.T.A.B. Feb. 23, 2018)
|
|
Cite Document
1003 Exhibit: Drach, J et al, Treatment of Mantle Cell Lymphoma Targeting the Micr...
Document
IPR2018-00685, No. 1003-3 Exhibit - Drach, J et al, Treatment of Mantle Cell Lymphoma Targeting the Microenvironment, Expert Review of Anticancer Therapy (P.T.A.B. Feb. 23, 2018)
|
|
Cite Document
1012 Exhibit: Wiernik, H et al, Preliminary Results from a Phase II Study of Lenalido...
Document
IPR2018-00685, No. 1012-12 Exhibit - Wiernik, H et al, Preliminary Results from a Phase II Study of Lenalidomide Monotherapy in Relapsed andor refractory Aggressive Non Hodgkins Lymphom...
|
|
Cite Document
1008 Exhibit: US Application No 12621,502, Declaration of Lei Zhang, MD dated De...
Document
IPR2018-00685, No. 1008-8 Exhibit - US Application No 12621,502, Declaration of Lei Zhang, MD dated Dec 18, 2013 (P.T.A.B. Feb. 23, 2018)
|
|
Cite Document
1009 Exhibit: US Application No 12621,502, Notice of Allowance and Fees Due issu...
Document
IPR2018-00685, No. 1009-9 Exhibit - US Application No 12621,502, Notice of Allowance and Fees Due issued Jan 22, 2014 (P.T.A.B. Feb. 23, 2018)
|
|
Cite Document
1011 Exhibit: Bartlett, JB et al, The evolution of thalidomide and its ImiD derivatives...
Document
IPR2018-00685, No. 1011-11 Exhibit - Bartlett, JB et al, The evolution of thalidomide and its ImiD derivatives as anticancer agents (P.T.A.B. Feb. 23, 2018)
|
|
Cite Document
1015 Exhibit: Dreyling, M et al, Treatment for patients with relapsed andor refractor...
Document
IPR2018-00685, No. 1015-15 Exhibit - Dreyling, M et al, Treatment for patients with relapsed andor refractory mantle cell lymphoma European based recommendations (P.T.A.B. Feb. 23, 2018)
|
|
Cite Document
1005 Exhibit: Querfeld, C et al, Preliminary Results of a Phase II Study of CC 5013 ...
Document
IPR2018-00685, No. 1005-5 Exhibit - Querfeld, C et al, Preliminary Results of a Phase II Study of CC 5013 Lenalidomide, Revlimid¿¿ in Patients with Cutaneous T Cell Lymphoma (P.T.A.B. Feb. 23...
|
|
Cite Document
1010 Exhibit: Harris, NL et al, World Health Organization Classification of neoplastic...
Document
IPR2018-00685, No. 1010-10 Exhibit - Harris, NL et al, World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues report of the clinical advisory co...
|
|
Cite Document
1016 Exhibit: Goy, A, New Directions in the Treatment of Mantle Cell Lymphoma An...
Document
IPR2018-00685, No. 1016-16 Exhibit - Goy, A, New Directions in the Treatment of Mantle Cell Lymphoma An Overview (P.T.A.B. Feb. 23, 2018)
|
|
Cite Document
1004 Exhibit: US Patent Application Publication No 20040029832
Document
IPR2018-00685, No. 1004-4 Exhibit - US Patent Application Publication No 20040029832 (P.T.A.B. Feb. 23, 2018)
|
|
Cite Document
1013 Exhibit: Revlimid¿¿ Lenalidomide Prescription Label published on December 2...
Document
IPR2018-00685, No. 1013-13 Exhibit - Revlimid¿¿ Lenalidomide Prescription Label published on December 27, 2005 (P.T.A.B. Feb. 23, 2018)
|
|
Cite Document
